Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
115372
Funder:
Pfizer
Topic:
Dementia and Cognitive Impairment Research
Subfield:
Psychiatry and Mental health
Field:
Medicine
Domain:
Health Sciences
Funded outputs count:
41
Funder award ID:
115372
OpenAlex ID:
G7511831505
Subcutaneous adipocyte glucocorticoid-responsive transcripts after modest weight gain in South Asian and White European men: an exploratory longitudinal study
2026
·
Xuan Gao
, Robin Lengton
, et al.
·
Metabologia
PDF
Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays
2026
·
Pieter J. van der Veere
, Argonde C. van Harten
, et al.
·
Alzheimer s & Dementia
PDF
Associations of lifestyle factors with amyloid pathology in persons without dementia
2025
·
Julie E Oomens
, Stephanie JB Vos
, et al.
·
Journal of Alzheimer s Disease
·
2
Synaptic protein CSF levels relate to memory scores in individuals without dementia
2025
·
Kirsten E. J. Wesenhagen
, Diederick M. de Leeuw
, et al.
·
Alzheimer s Research & Therapy
·
4
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
2023
·
Alexander Neumann
, Olena Ohlei
, et al.
·
Genome Medicine
·
23
PDF
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation
2022
·
Alexander Neumann
, Fahri Küçükali
, et al.
·
Molecular Psychiatry
·
25
PDF
Identification of Rare Loss-of-Function Genetic Variation Regulating Body Fat Distribution
2021
·
Mine Koprulu
, Yajie Zhao
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
36
PDF
White matter microstructural differences in children and genetic risk for multiple sclerosis: A population-based study
2021
·
C Louk de Mol
, Rinze F Neuteboom
, et al.
·
Multiple Sclerosis Journal
·
7
CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
2021
·
Betty Tijms
, Johan Gobom
, et al.
·
Proteomes
·
23
PDF
Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
2020
·
Shengjun Hong
, Dmitry Prokopenko
, et al.
·
Translational Psychiatry
·
72
PDF
Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics
2020
·
Betty M Tijms
, Johan Gobom
, et al.
·
Brain
·
222
PDF
Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum
2020
·
Mark A. Dubbelman
, Roos J. Jutten
, et al.
·
Alzheimer s Research & Therapy
·
76
PDF
Metabolic Age Based on the BBMRI-NL 1 H-NMR Metabolomics Repository as Biomarker of Age-related Disease
2020
·
E.B. van den Akker
, S. Trompet
, et al.
·
Circulation Genomic and Precision Medicine
·
117
PDF
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
2020
·
Elles Konijnenberg
, Betty M. Tijms
, et al.
·
Alzheimer s Research & Therapy
·
54
PDF
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
2019
·
Lisa Vermunt
, Sietske A.M. Sikkes
, et al.
·
Alzheimer s & Dementia
·
715
PDF
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
2019
·
Min Kim
, Stuart Snowden
, et al.
·
Alzheimer s & Dementia
·
105
PDF
An exploratory phenome wide association study linking asthma and liver disease genetic variants to electronic health records from the Estonian Biobank
2019
·
Glen James
, Sulev Reisberg
, et al.
·
PLoS ONE
·
11
PDF
Atrophy subtypes in prodromal Alzheimer’s disease are associated with cognitive decline
2018
·
Mara ten Kate
, Ellen Dicks
, et al.
·
Brain
·
165
PDF
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data
2018
·
Isabelle Bos
, Stephanie J. B. Vos
, et al.
·
Frontiers in Aging Neuroscience
·
41
Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults
2018
·
Mara ten Kate
, Pieter Jelle Visser
, et al.
·
Frontiers in Aging Neuroscience
·
45
PDF
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
2018
·
Charlotte E. Teunissen
, Markus Otto
, et al.
·
Alzheimer s Research & Therapy
·
60
PDF
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia
2017
·
Willemijn J. Jansen
, Rik Ossenkoppele
, et al.
·
JAMA Psychiatry
·
167
PDF
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
2017
·
Piotr Lewczuk
, Peter Riederer
, et al.
·
The World Journal of Biological Psychiatry
·
341
PDF
Does genetic risk help to predict amyloid burden in a non-demented population? A Bayesian approach
2017
·
Nicola Voyle
, Willemijn Jansen
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
2017
·
Davide Chiasserini
, Leonardo Biscetti
, et al.
·
Alzheimer s Research & Therapy
·
147
PDF
Show more works
View as search